IAC Executive Council Slate 2013-2016
The Membership of the International Academy of Cytology voted for the Executive Council 2013 - 2016
Philippe Vielh, France
Philippe Vielh was born in Aix-en-Provence (France). He graduated as an MD and a board-certified pathologist from the Faculty of Medicine, and as a PhD in Immunology from the Institut Pasteur, both in Paris (France). He has a "Habilitation à Diriger des Recherches" (HDR) from the Faculty of Sciences. He has been heading the Cytopathology Unit at the Institut Curie (Paris) for thirteen years, then moved to Gustave Roussy Cancer Campus (Villejuif, near Paris) where he is Director of Cytopathology (2003-present), Head of the Histo-Cyto-Pathology Unit (2007-present) of the Translational Research Laboratory and Head of the institutional Biobank (2011-present). He is particularly interested in the study of genomics and transcriptomics of breast and thyroid tumors and a member of the U981 INSERM (Institut National de la Recherche Scientifique). He is author or co-author of more than 240 articles, published in peer-reviewed journals, 15 book chapters and 5 books. He served as President of the French Society of Clinical Cytology (SFCC) for 10 years (1996-2006) and organized the 31st European Congress of Cytology in Paris (2005), where he was elected Secretary General of the European Federation of Cytology Societies (EFCS) and served from 2005 till 2012. He is the recipient of the 2007 L.C. Tao "Educator of the Year" award given by the Papanicolaou Society of Cytopathology, and a Fellow of the IAC. He chaired the 18th IAC congress in Paris (May 26-30, 2013) and is currently the President of IAC for the 2013-2016 period of time.
Robert Y. Osamura, Japan
Dr. Robert Y. Osamura, MD, FIAC is Professor and Director of Diagnostic Pathology Center at International University of Health and Welfare and served as Chairman of the Japanese Society of Clinical Cytology(JSCC), the largest national society of cytology worldwide with over 11.000 members. Dr. Osamura graduated from Keio University School of Medicine in Tokyo, and trained in pathology at University of Colorado Medical Center, Denver, Colorado, USA and completed a Fellowship at Henry Ford Hospital, Detroit, Michigan.
His research interests focused on the application of immunohistochemical techniques to diagnostic pathology and cytology leading him lately into the field of molecular pathology & cytology. Currently, he is involved in developing roles for morphology in molecular targeted cancers therapy in the areas of breast cancers, GIST, lung cancers and colo-rectal cancers. He is particularly interested in emphasizing the significance of cytological material as source of good targets for the application of various molecular techniques.
Dr. Osamura has been serving as a member of numerous Editorial Boards in cytology and also pathology. Dr. Osamura organized the 47th Annual Meeting of JSCC in Yokohama in 2006 which attracted 4700 attendees. Since 2004 Dr. Osamura has been on the Executive Council of the IAC, serving as Vice President and as a Chair of Constitution and By-Laws Committee. For 2010-2013, as Vice President, he is looking forward to working hard with all of the members of IAC for "global encouragement and interaction in cytological activities" for the best in diagnosis, therapy and prevention of the diseases.
Diane Solomon, U.S.A.
Diane Solomon, M.D. is a Senior Investigator at the National Cancer Institute in Washington, USA. Currently, Dr. Solomon is working with a team conducting an NCI sponsored clinical trial of a prophylactic HPV vaccine in Costa Rica. She previously headed the NCI ALTS clinical trial with over 5,000 women to determine the optimal management of equivocal and mildly abnormal Pap tests. The results of ALTS have formed the basis for consensus guidelines for management of women with abnormal cytology results and have changed national practice patterns. She has also been instrumental in the development and evolution of the Bethesda System for communicating the results of cervical cytology, and in the development of screening guidelines. Dr. Solomon's research and writings bring a balanced perspective to cervical cancer screening issues, emphasizing the successes and also inherent limitations of the screening process and incorporation of new technologies. She has authored or co-authored over 120 scientific articles, six book chapters, and presented over 250 lectures and workshops, nationally and internationally.
Andrew Field, Australia
Dr Field graduated from medicine at University of New South Wales in 1978, completed his FRCPA anatomical pathology training in 1985, and then pursued further training in cytopathology at John Hopkins, Karolinska and Flinders Hospitals leading to him gaining the FIAC in 1990 and the RCPA Cytology Diploma in 1996.
He is Deputy Director and senior consultant in the Department of Tissue and Molecular Pathology at St Vincent's Hospital, Sydney, senior lecturer at the University of New South Wales, and Adjunct Professor at Notre Dame Medical School, Sydney.
He is a past president of the Australian Society of Cytology, past Board member of the Papanicolaou Society of Cytology and is a member of the IAC Task Force for promoting education and professional development in cytology in developing countries and the IAC Membership and Site Selection Committees. He is on the editorial board and reviews for Diagnostic Cytopathology, Cancer Cytopathology, ACTA Cytologica and Cytojournal.
With the support of the Papanicolaou Society and local organizers, he has organized and taught at twelve FNB tutorials in Kampala, Lagos, Kano, Dar Es Salaam, Cape Town and Nairobi, commencing in 2007, with Dr William Geddie, Toronto, Dr Matthew Zarka, Scottsdale, and other colleagues. Further tutorials have been organized for Ethiopia in 2013, and he is committed to fostering the development of cytopathology in the developing world.
His major diagnostic, teaching, publication, writing and research interests are in FNB cytology, especially of the lymph nodes, breast, infectious diseases and thyroid, and in breast, infections including AIDS, and gastrointestinal surgical pathology. In 2011, he received the Papanicolaou Society Award for Interventional Cytopathologist of the Year.
He is Director of the East Pennine Cytology Training Centre (which he founded as the Sheffield Cytology Training Centre in 1991), Director of South Yorkshire & Bassetlaw Cervical Cytology Service and lead histopathologist at Sheffield Gynaecological Cancer Centre. He is a former Chair of the Cytopathology Sub-Committee and the Panel of Examiners in Cytology of the Royal College of Pathologists and past President of the British Society for Clinical Cytology. He was chair of the organising committee and co-chair of the scientific programme committee of the 17th International Congress of Cytology held in Edinburgh in 2010.
Dr Smith has published over 80 original papers, a book, book chapters and review articles and has lectured and conducted slide seminars on cervical cytology, cervical cancer screening and gynaecological histopathology throughout the UK and in Europe, South America, the Middle East, South East Asia and Australasia.
He has recently authored revised quality assurance guidelines for the UK cervical screening programme and his laboratory has made a major contribution to studies on the use of human papillomavirus testing in cervical cancer screening.
Fernando Schmitt was Professor of Pathology at the University of Porto, Portugal and served as Medical Director of the Unit of Pathology at Institute of Pathology and Immunology of Porto University (IPATIMUP) during the last twenty years. He was born in Brazil in 1959 and received his medical degree in 1983. Fernando served his pathology residency at the Medical Faculty of Botucatu, São Paulo, performed a fellowship in Clinical Cytology at Karolinska Hospital, Stockholm and earned his PhD in Pathology in 1990. After ten years in the University of São Paulo, Fernando moved to Portugal in 1993. He established a research group in breast pathology and a FNA service at IPATIMUP. Dr. Schmitt holds 12 national and international society memberships, including FIAC. Dr. Schmitt has authored more than 370 papers in peer-review journals and 23 book chapters. He serves as Associate Editor of Diagnostic Cytopathology, Acta Cytologica and BMC Cancer and belongs on the Editorial board for a number of journals. Dr. Schmitt has served on various national and international committees of Pathology and Cytology Societies. Currently, he is the Secretary-General of the International Academy of Cytology. Dr Schmitt organized the 35th European Congress of Cytology in Lisbon in September 2009. He was awarded as Educator of the Year 2011 by the Papanicoloau Society of Cytology (USA) and received The 2013 Maurice Goldblatt Cytology Award from the International Academy of Cytology. Teaching medical students, research in breast pathology and performing and diagnosing FNA's are his favorite activities. In September 2013 Fernando joined the Medical Faculty of the University of Toronto as Professor of Pathology and the University Health Network/Toronto General Hospital as cytopathologist at the Department of Laboratory Medicine and Pathobiology.
Hold for picture
|Luis M. Collaço, Brasil
Hold for text
|Annabelle Farnsworth, Australia
Dr. Annabelle Farnsworth is the medical director of Douglass Hanly Moir Pathology (DHM) and the director of the DHM Cytopathology Department, the largest cytology department in Australia reporting on both gynaecological and non-gynaecological cytology specimens. She has an ongoing interest in cervical screening, quality assurance in cytology, automation in cervical cytology and medical education. She is currently the Australian Society of Cyology representative on the federal government review panel looking at quality standards in cervical cytology. She has published widely including investigations into automation in cervical cytology.
|Ui Soon Khoo, Hong Kong
Dr. Ui-Soon Khoo is a Clinical Professor in the Department of Pathology, The University of Hong Kong and Deputy Director of the University Pathology Laboratory. She obtained her medical degree from the University College Galway, Ireland in 1984 before joining The University of Hong Kong where she did her postgraduate pathology specialist training in Queen Mary Hospital. She is a Fellow of the Royal College of Pathologists, UK and a Fellow of the Hong Kong Academy of Medicine. Dr Khoo obtained her higher doctorate in research (MD degree), from The University of Hong Kong, on genetic susceptibility to breast and ovarian cancer. She is also an Honorary Consultant Pathologist at Queen Mary Hospital, Hong Kong and served as President of the Hong Kong Society of Cytology (2008-2010), Chairman of the Hong Kong Pathology Society (1996-1998). She has organized several slide seminars, courses and other activities related to pathology and cytology and was Co-Director of the IAC Tutorial 2012 conducted in Hong Kong. Teaching at the undergraduate and post-graduate level as well as research in breast pathology, are among her special interests for which she has published widely.
|Kusum Kapila, Kuwait
Dr. Kapila is Professor of Pathology and Head of Cytopathology at the Kuwait University. She completed post graduation residency program in Pathology at All India Institute of Medical Sciences (AIIMS) , New Delhi (India) and performed a post doctoral fellowship in Cytopathology at the Memorial Sloan Kettering Institute, New York. She earned her Masters in Medical Education degree from Dundee and is currently the Program Director of the Graduate Studies in Pathology (Masters and Ph.D) at Kuwait University. She serves as Editor and reviewer for several journals. Dr. Kapila was Head of Cytopathology at AIIMS and served as Secretary, Treasurer and Convenor of the Accreditation and Examination Committee of the Indian Academy of Cytologists. She has organized several symposia and workshops and has been a resource person in national and international meetings where she has been the recipient of several awards.Teaching medical students and diagnostic cytopathology are her special interests.
|Ritu Nayar, USA
Ritu Nayar graduated from Maulana Azad Medical College, Delhi India, with an MBBS and MD in Pathology. She then moved to the United States and completed her Pathology residency, Surgical Pathology and Cytopathology fellowships. Currently Dr Nayar is a Professor of Pathology and Director of Cytopathology at Northwestern University, Chicago.
Dr. Nayar's practice includes clinical service, administration, teaching and translational research. She has published over 100 journal articles and book chapters; is co-editor of the 2nd edition of the Bethesda Atlas for Reporting Cervical Cytology Bethesda Atlas; contributor for the Bethesda System for Reporting Thyroid Cytopathology and an editorial board member for several pathology journals. She is a frequently invited speaker for American and International Pathology Meetings.
Dr Nayar has been an active leader in Pathology, having chaired and served on several committees in the ASC, ASCP, USCAP,CAP and PSC. Currently Ritu Nayar is President Elect of the American Society of Cytopathology, Chair of the International Academy of Cytology (IAC) Education Committee, and a member of the CAP Cytopathology Committee.
Shirley Greening, U.S.A.
At Thomas Jefferson University in Philadelphia, USA since 1983, Ms. Greening is Professor and Chairman of the Department of Bioscience Technologies, which conducts BS and MS programs in Biotechnology, Cytotechnology/Cell Sciences and Medical Laboratory Science.
Ms. Greening has been Chair of the Cytotechnology Advisory Committee of the American Society of Cytopathology (ASC), and is a Past-President of the American Society for Cytotechnology (ASCT).
An active member of the IAC since 1972, she is Chair of the IAC's Cytotechnology Awards Jury.
With interests in national and international education and practice issues, Ms. Greening is currently serving on the International Advisory Board for King Saud bin Abdulaziz University of Health Sciences in Riyadh, Saudi Arabia and is a member of ASCP's International Certification Committee.
She received the Cytotechnologist of the Year Award from the ASC in 1993, the Cytotechnologist Achievement Award of the American ASCT in 1995, and the 1997 Cytotechnology Award in Clinical Cytology from the IAC.